Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Health

New Market Research Report: Bahrain Pharmaceuticals & Healthcare Report Q1 2013


Print article Print article
2013-02-19 10:07:55 - New Healthcare research report from Business Monitor International is now available from Fast Market Research

BMI View: We expect Bahrain's pharmaceutical market values to grow steadily over the coming years. Key drivers will be volume-based, as the growing population increasingly requires more sophisticated treatments for lifestyle diseases and as healthcare provision expands and modernises. However, while some investment has been made into the local pharmaceutical manufacturing industry, imports will continue to supply the bulk of the demand.

Headline Expenditure Projections

* Pharmaceuticals: BHD90mn (US$240mn) in 2011 to BHD100mn (US$260mn) in 2012; +6.12% in both local currency and US dollar terms. Forecast unchanged from Q412.
* Healthcare: BHD420mn (US$1.1bn) in 2011 to BHD500mn (US$1.2bn); +7.3% in both local currency and US dollar terms. Forecast unchanged from Q412.
* Medical devices: BHD30mn (US$70mn) in 2011 to BHD30mn (US$70mn)

in 2012; +11.3% in both local currency and US dollar terms. Forecast unchanged from Q412.


Full Report Details at
- www.fastmr.com/prod/536395_bahrain_pharmaceuticals_healthcare_re ..


Risk/Reward Rating: In our Q113 version of our Pharmaceutical Risk/Reward Ratings (RRRs) matrix for the Middle East and Africa (MEA), Bahrain is still ranked seventh out of the 30 markets surveyed in the region. The country's composite score is unchanged, at 54.9 out of the maximum 100. The country's position is propped up by its favourable risks profile, as its longer term rewards potential remains weighted down by its small population numbers. Globally, Bahrain ranks 38th out of the 95 markets assessed in total using our RRR model.

Key Trends And Developments

* In October 2012, it was reported that the Bahraini Ministry of Health will invest BHD270mn (US$718.08mn) in 18 new projects under the Gulf Co-operation Council (GCC)'s 'Marshall Plan'. The ministry, which has prepared a timetable to implement the projects, has already approved the construction of a 60-bed dialysis centre in the Southern Governorate, according to under-secretary for hospital affairs Amin al-Saati. Other projects in the pipeline include a hospital to treat chronic diseases in Muharraq, as well specialised diabetes, health and rehabilitation centres.
* In November 2012, The Gulf Daily News reported that the Minister of Health, Sadiq Al Shehabi, is holding talks with the country's medical professionals. The talks reassess a decision to ban doctors from working in both public and private sectors. The ban is due to come into force from the start of 2013, as part of the authorities' attempt to reduce public sector waiting lists and

Report Table of Contents:

Executive Summary
SWOT Analysis
- Bahrain Pharmaceuticals And Healthcare Industry SWOT Analysis
- Bahrain Political SWOT Analysis
- Bahrain Economic SWOT Analysis
- Bahrain Business Environment SWOT Analysis
Pharmaceutical Risk/Reward Ratings
- Table: Middle East And Africa Pharmaceutical Risk/Reward Ratings, Q113
- Rewards
- Risks
Bahrain - Market Summary
Regulatory Regime
- GCC Harmonisation
- Intellectual Property Regime
- Pricing And Reimbursement Regime
- Free Trade Agreement With The US
- Other Free Trade Agreements
Industry Developments
- Epidemiology
- Non-Communicable Diseases
- Table: Leading Causes Of Death In Bahrain, 2008
- HIV/AIDS
- Healthcare Sector
- Recent Healthcare Sector Developments
- Primary, Secondary And Tertiary Healthcare
- Table: Ministry of Health's Objectives
- Health Insurance
- Table: National Health Insurance Scheme Breakdown
- Healthcare Sector Investment
- Table: Features Of Dilmunia Health Island
- Information Technology In Healthcare
- Research And Development
- Clinical Trials
- Medical Devices
Industry Forecast Scenario
- Pharmaceutical Market Forecast
- Table: Pharmaceutical Sales Indicators, 2008-2016
- Healthcare Market Forecast
- Table: Healthcare Expenditure Indicators, 2008-2016
- Table: Healthcare Governmental Indicators, 2008-2016
- Table: Healthcare Private Indicators, 2008-2016
- Key Growth Factors - Macroeconomic
- Table: Macro Indicators
- Prescription Drug Market Forecast
- Table: Prescription Drug Sales Indicators, 2008-2016
- Patented Drug Market Forecast
- Table: Patented Drug Market Indicators, 2008-2016
- Generic Drug Market Forecast
- Table: Generic Drug Sales Indicators, 2008-2016
- OTC Medicine Market Forecast
- Table: OTC Medicine Sales Indicators, 2008-2016
- Pharmaceutical Trade Forecast
- Table: Exports and Imports Indicators, 2008-2016
- Medical Device Market Forecast
- Table: Medical Devices Sales Indicators, 2008-2016
- Other Healthcare Data Forecasts
- Key Risks To BMI's Forecast Scenario
Competitive Landscape
- Pharmaceutical Industry
- Domestic Industry
- Company Developments
- Pharmaceutical Retail
Company Profiles
- Local Companies
- Al-Jishi Corporation
- Bahrain Industrial Pharmaceutical Co (Bidapharm)
- Behzad Medical Establishment
- Yousuf Mahmood Husain Company
- Multinational Companies
- GlaxoSmithKline
- Novartis
- Johnson & Johnson
- Merck & Co
- Pfizer
- Sanofi
Demographic Outlook
- Table: Bahrain's Population By Age Group, 1990-2020 ('000)
- Table: Bahrain's Population By Age Group, 1990-2020 (% of total)
- Table: Bahrain's Key Population Ratios, 1990-2020
- Table: Bahrain's Rural And Urban Population, 1990-2020
Glossary
BMI Methodology
- How We Generate Our Pharmaceutical Industry Forecasts
- Pharmaceutical Risk/Reward Ratings Methodology
- Ratings Overview
- Table: Pharmaceutical Risk/Reward Indicators
- Weighting
- Table: Weighting Of Components
- Sources

About Business Monitor International

Business Monitor International (BMI) offers a comprehensive range of products and services designed to help senior executives, analysts and researchers assess and better manage operating risks, and exploit business opportunities, across 175 markets. BMI offers three main areas of expertise: Country Risk BMI's country risk and macroeconomic forecast portfolio includes weekly financial market reports, monthly regional Monitors, and in-depth quarterly Business Forecast Reports. Industry Analysis BMI covers a total of 17 industry verticals through a portfolio of services, including in-depth quarterly Country Forecast Reports. View more research from Business Monitor International at www.fastmr.com/catalog/publishers.aspx?pubid=1010

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.


Author:
Bill Thompson
e-mail
Web: www.fastmr.com
Phone: 18008448156

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com